Antimicrobial peptides´ immune modulation role in intracellular bacterial infection

19Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Intracellular bacteria cause a wide range of diseases, and their intracellular lifestyle makes infections difficult to resolve. Furthermore, standard therapy antibiotics are often unable to eliminate the infection because they have poor cellular uptake and do not reach the concentrations needed to kill bacteria. In this context, antimicrobial peptides (AMPs) are a promising therapeutic approach. AMPs are short cationic peptides. They are essential components of the innate immune response and important candidates for therapy due to their bactericidal properties and ability to modulate host immune responses. AMPs control infections through their diverse immunomodulatory effects stimulating and/or boosting immune responses. This review focuses on AMPs described to treat intracellular bacterial infections and the known immune mechanisms they influence.

Cite

CITATION STYLE

APA

Duarte-Mata, D. I., & Salinas-Carmona, M. C. (2023). Antimicrobial peptides´ immune modulation role in intracellular bacterial infection. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2023.1119574

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free